Termination for Non-Issuance of Valid DTI Patent. Fujisawa may terminate this Agreement in its entirety for non-issuance of the DTI Patent pursuant to Section 5.3(a).
Appears in 3 contracts
Sources: Development and License Agreement (Aderis Pharmaceuticals Inc), Development and License Agreement (Aderis Pharmaceuticals Inc), Development and License Agreement (Aderis Pharmaceuticals Inc)